Results 161 to 170 of about 3,107 (205)

EE424 Societal Costs of Spinal Muscular Atrophy Type 1 for Patients Treated with Onasemnogene Abeparvovec or Nusinersen in the United Kingdom [PDF]

open access: bronze
J. Kleintjens   +6 more
openalex   +1 more source

The efficacy of gene therapy with onasemnogene abeparvovec in spinal muscular atrophy in young patients

L O Badalyan Neurological Journal
Introduction. The advent of pathogenetic therapy has significantly changed the prognosis for spinal muscular atrophy (SMA). However, our knowledge of the pathogenetic methods of treating SMA is mostly based on the results of clinical trials, which are ...
D. A. Fisenko   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy